{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:53:18Z","timestamp":1761648798939,"version":"3.40.5"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T00:00:00Z","timestamp":1601856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Medicine and Surgery"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.amsu.2020.10.002","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T15:54:41Z","timestamp":1602086081000},"page":"27-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Effects of vonoprazan on gastric PH and clinical course after gastric ESD: A retrospective and prospective study"],"prefix":"10.1097","volume":"60","author":[{"given":"Daisuke","family":"Suto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5722-0843","authenticated-orcid":false,"given":"Masashi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Otake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichiro","family":"Ichiishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumoto","family":"Murata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotoshi","family":"Ebinuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Odaira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Kohgo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"6","key":"10.1016\/j.amsu.2020.10.002_bib1","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/apt.13325","article-title":"Acid-inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects\u2014a randomized open-label cross-over study","volume":"42","author":"Sakurai","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.amsu.2020.10.002_bib2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40265-015-0368-z","article-title":"Vonoprazan: first global approval","volume":"75","author":"Garnock-Jones","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.amsu.2020.10.002_bib3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1124\/jpet.110.170274","article-title":"1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate (TAK-438), a novel and potent potassium-competitive acid blocker for the treatment of acid-related diseases","volume":"335","author":"Hori","year":"2010","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.amsu.2020.10.002_bib4","doi-asserted-by":"crossref","DOI":"10.1177\/1756283X17745776","article-title":"Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: safety and clinical evidence to date","volume":"11","author":"Sugano","year":"2018","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.amsu.2020.10.002_bib5","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.bcp.2011.02.009","article-title":"A comparative study on the modes of action of TAK-438, a novel potassium-competitive acid blocker, and lansoprazole in primary cultured rabbit gastric glands","volume":"81","author":"Matsukawa","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.amsu.2020.10.002_bib6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.21037\/atm.2017.02.12","article-title":"Complications following endoscopic submucosal dissection for gastric, esophageal, and colorectal cancer: a review of studies based on nationwide large-scale databases","volume":"5","author":"Odagiri","year":"2017","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.amsu.2020.10.002_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4253\/wjge.v8.i3.173","article-title":"Second-look endoscopy and factors associated with delayed bleeding after endoscopic submucosal dissection","volume":"8","author":"Kim","year":"2016","journal-title":"World J. Gastrointest. Endosc."},{"key":"10.1016\/j.amsu.2020.10.002_bib8","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1440-1746.2011.07039.x","article-title":"Risk factors for perforation and delayed bleeding associated with endoscopic submucosal dissection for early gastric neoplasms: analysis of 1123 lesions","volume":"27","author":"Toyokawa","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.amsu.2020.10.002_bib9","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1007\/s00464-014-3457-2","article-title":"Clinical outcomes of second-look endoscopy after gastric endoscopic submucosal dissection: predictive factors with high risks of bleeding","volume":"28","author":"Choi","year":"2014","journal-title":"Surg. Endosc."},{"key":"10.1016\/j.amsu.2020.10.002_bib10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00535-009-0137-4","article-title":"Risk factors for complications of endoscopic submucosal dissection in gastric tumors: analysis of 478 lesions","volume":"45","author":"Mannen","year":"2010","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.amsu.2020.10.002_bib11","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1365-2036.2006.03050.x","article-title":"Omeprazole may be superior to famotidine in the management of iatrogenic ulcer after endoscopic mucosal resection: a prospective randomized controlled trial","volume":"24","author":"Ye","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.amsu.2020.10.002_bib12","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/j.1572-0241.2007.01197.x","article-title":"Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial","volume":"102","author":"Uedo","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.amsu.2020.10.002_bib13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000331138","article-title":"Proton pump inhibitors versus histamine-2-receptor antagonists for the management of iatrogenic gastric ulcer after endoscopic mucosal resection or endoscopic submucosal dissection: a meta-analysis of randomized trials","volume":"84","author":"Yang","year":"2011","journal-title":"Digestion"},{"key":"10.1016\/j.amsu.2020.10.002_bib14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/apt.13747","article-title":"Vonoprazan prevents bleeding from endoscopic submucosal dissection-induced gastric ulcers","volume":"44","author":"Kagawa","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.amsu.2020.10.002_bib15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s00535-018-1487-6","article-title":"Efficacy of vonoprazan in prevention of bleeding from endoscopic submucosal dissection-induced gastric ulcers: a prospective randomized phase II study","volume":"54","author":"Hamada","year":"2019","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.amsu.2020.10.002_bib16","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/den.12857","article-title":"Effect of vonoprazan on the treatment of artificial gastric ulcers after endoscopic submucosal dissection: prospective randomized controlled trial","volume":"29","author":"Tsuchiya","year":"2017","journal-title":"Dig. Endosc."},{"key":"10.1016\/j.amsu.2020.10.002_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/den.12705","article-title":"Vonoprazan is superior to proton pump inhibitors in healing artificial ulcers of the stomach post-endoscopic submucosal dissection: a propensity score-matching analysis","volume":"29","author":"Maruoka","year":"2017","journal-title":"Dig. Endosc."},{"key":"10.1016\/j.amsu.2020.10.002_bib18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijsu.2017.08.586","article-title":"The STROCSS statement: strengthening the reporting of cohort studies in surgery","volume":"46","author":"Agha","year":"2017","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.amsu.2020.10.002_bib19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10120-011-0041-5","article-title":"Japanese classification of gastric carcinoma: 3rd English edition","volume":"14","author":"Japanese Gastric Cancer Association","year":"2011","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.amsu.2020.10.002_bib20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0016-5085(78)90352-9","article-title":"Effect of acid and pepsin on blood coagulation and platelet aggregation: a possible contributor prolonged gastroduodenal mucosal hemorrhage","volume":"74","author":"Green","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amsu.2020.10.002_bib21","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1440-1746.2007.05059.x","article-title":"Low-dose intravenous pantoprazole for optimal inhibition of gastric acid in Korean patients","volume":"22","author":"Oh","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.amsu.2020.10.002_bib22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0016-5107(04)01683-9","article-title":"Healing rate of EMR-induced ulcer in relation to the duration of treatment with omeprazole","volume":"60","author":"Lee","year":"2004","journal-title":"Gastrointest. Endosc."},{"key":"10.1016\/j.amsu.2020.10.002_bib23","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00535-011-0447-1","article-title":"Effect of lansoprazole versus roxatidine on prevention of bleeding and promotion of ulcer healing after endoscopic submucosal dissection for superficial gastric neoplasia","volume":"46","author":"Imaeda","year":"2011","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.amsu.2020.10.002_bib24","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/apt.13121","article-title":"Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects","volume":"41","author":"Jenkins","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.amsu.2020.10.002_bib25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.clpt.2005.09.012","article-title":"Acid-suppressive effects of rabeprazole, omeprazole, and lansoprazole at reduced and standard doses: a crossover comparative study in homozygous extensive metabolizers of cytochrome P450 2C19","volume":"79","author":"Shimatani","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.amsu.2020.10.002_bib26","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/apt.13876","article-title":"Randomised clinical trial: efficacy and safety of vonoprazan vs lansoprazole in patients with gastric or duodenal ulcers \u2013 results from two phase 3, non-inferiority randomised controlled trials","volume":"45","author":"Miwa","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.amsu.2020.10.002_bib27","doi-asserted-by":"crossref","first-page":"716","DOI":"10.4253\/wjge.v8.i19.716","article-title":"Vonoprazan 20 mg vs lansoprazole 30 mg for endoscopic submucosal dissection-induced gastric ulcers","volume":"8","author":"Takahashi","year":"2016","journal-title":"World J. Gastrointest. Endosc."}],"container-title":["Annals of Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2049080120303551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2049080120303551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T16:10:01Z","timestamp":1677082201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2049080120303551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":27,"alternative-id":["S2049080120303551"],"URL":"https:\/\/doi.org\/10.1016\/j.amsu.2020.10.002","relation":{},"ISSN":["2049-0801"],"issn-type":[{"type":"print","value":"2049-0801"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of vonoprazan on gastric PH and clinical course after gastric ESD: A retrospective and prospective study","name":"articletitle","label":"Article Title"},{"value":"Annals of Medicine and Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amsu.2020.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.","name":"copyright","label":"Copyright"}]}}